A Comparison Study of PF708 and Forteo in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Osteoporosis
Interventions
DRUG

Teriparatide

Single subcutaneous injection

Trial Locations (1)

47710

Covance Clinical Research Unit, Evansville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfenex, Inc

INDUSTRY